Pathways of reductive fragmentation of heterocyclic nitroarylmethyl quaternary ammonium prodrugs of mechlorethamine

Radiation Research

Volumn 158, Issue 6, 2002, Pages 753-762

  Kriste, Angela G ^a   Tercel, Moana ^a   Anderson, Robert F ^a   Fery, Dianne M ^a   Wilson, William R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 2 [2 (1 METHYL 5 NITROPYRROL 2 YL)ETHYL] 5 NITROPYRROLE; 1,3 DIMETHYL 2 NITROPYRROLE; 1,4 DIMETHYL 5 NITROPYRAZOLE; 1,5 DIMETHYL 4 NITROIMIDAZOLE; 1,5 DIMETHYL 4 NITROPYRAZOLE; 2 METHYL 3 NITROTHIOPHENE; 4 NITROIMIDAZOLE DERIVATIVE; 5 METHYL 4 NITROIMIDAZOLE; ANION; BENZYL DERIVATIVE; BUFFER; CHLORMETHINE; CYTOTOXIN; DIMER; ETHYL 1,4 DIMETHYL 5 NITROPYRROLE 2 CARBOXYLATE; FORMIC ACID; HETEROCYCLIC COMPOUND; MARKER; NITRO DERIVATIVE; PRODRUG; PYRAZOLE DERIVATIVE; PYRROLE DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE; RADICAL; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; ELECTRON; FRAGMENTATION REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; MASS SPECTROMETRY; PRIORITY JOURNAL; PULSE RADIOLYSIS; RADIOLYSIS; REACTION ANALYSIS; REDUCTION; RELIABILITY; STEADY STATE;

EID: 0036895522     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2002)158[0753:PORFOH]2.0.CO;2     Document Type: Article

References (39)

1. 2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 26, 45-50 (1993).
2. M. Nordsmark, M. Overgaard and J. Overgaard, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41, 31-39 (1996).
3. A. W. Fyles, M. Milosevic, R. Wong, M. C. Kavanagh, M. Pintilie, A. Sun, W. Chapman, W. Levin, L. Manchul and R. P. Hill, Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother. Oncol. 48, 149-156 (1998).
4. D. Shweiki, A. Itin, D. Soffer and E. Keshet, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845 (1992).
5. A. Hartmann, M. Kunz, S. Kostlin, R. Gillitzer, A. Toksoy, E. Brocker and C. E. Klein, Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res. 59, 1578-1583 (1999).
6. T. G. Graeber, C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe and A. J. Giaccia, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91 (1996).
7. C. Y. Kim, M. H. Tsai, C. Osmanian, T. G. Graeber, J. E. Lee, R. G. Giffard, J. A. DiPaolo, D. M. Peehl and A. J. Giaccia, Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res. 57, 4200-4204 (1997).
8. J. M. Brown, The hypoxic cell: A target for selective cancer therapy - Eighteenth Bruce E Cain memorial lecture. Cancer Res. 59, 5863-5870 (1999).
9. J. M. Brown, Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies. Mol. Med. Today 6, 157-162 (2000).
10. A. M. Rauth, T. Melo and V. Mistra, Bioreductive therapies: An overview of drugs and their mechanisms of action. Int. J. Radiat. Oncol. Biol. Phys. 42, 755-762 (1998).
11. M. Jaffar and I. J. Stratford, Bioreductive drugs: Selectivity towards hypoxic tissue. Expert Opin. Ther. Pat. 9, 1371-1380 (1999).
12. B. G. Siim, W. A. Denny and W. R. Wilson, Nitro reduction as an electronic switch for bioreductive drug activation. Oncol. Res. 9, 357-369 (1997).
13. P. Wardman, Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia. Curr. Med. Chem. 8, 739-761 (2001).
14. K. I. Wijffels, J. H. Kaanders, P. F. Rijken, J. Bussink, F. J. van den Hoogen, H. A. Marres, P. C. de Wilde, J. A. Raleigh and A. J. van der Kogel, Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. Br. J. Cancer 83, 674-683 (2000).
15. R. S. Marshall and A. M. Rauth, Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells. Cancer Res. 48, 5655-5659 (1988).
16. C. J. Koch, Unusual oxygen concentration dependence of toxicity of SR 4233, a hypoxic cell toxin. Cancer Res. 53, 3992-3997 (1993).
17. B. G. Siim, G. J. Atwell and W. R. Wilson, Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs. Br. J. Cancer 70, 596-603 (1994).
18. W. A. Denny and W. R. Wilson. Bioreducible mustards: A paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs). Cancer Metastasis Rev. 12, 135-151 (1993).
19. M. Tercel, W. R. Wilson and W. A. Denny, Nitrobenzyl mustard quaternary salts: A new class of hypoxia-selective cytotoxins showing very high in vitro selectivity. J. Med. Chem. 36, 2578-2579 (1993).
20. W. A. Denny, W. R. Wilson, M. Tercel, P. van Zijl and S. M. Pullen, Nitrobenzyl mustard quaternary salts: A new class of hypoxia-selective cytotoxin capable of releasing diffusible cytotoxins on bioreduction. Int. J. Radiat. Oncol. Biol. Phys. 29, 317-321 (1994).
21. M. Tercel, W. R. Wilson, R. F. Anderson and W. A. Denny, Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. J. Med. Chem. 39, 1084-1094 (1996).
22. M. Tercel, A. E. Lee, A. Hogg, R. F. Anderson, H. H. Lee, B. G. Siim, W. A. Denny and W. R. Wilson, Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. J. Med. Chem. 44, 3511-3522 (2001).
23. W. R. Wilson, W. A. Denny and M. Tercel, Radiation-activated cytotoxins: A new use for Roentgen's rays in cancer treatment. In Radiation Research, 1895-1995, Vol. 2 (U. Hagen, D. Harden, H. Jung and C. Streffer, Eds.), pp 791-793. Universitatsdruckerei H. Sturtz AG, Wurzburg, 1995.
24. W. R. Wilson, M. Tercel, R. F. Anderson and W. A. Denny, Radiation-activated prodrugs as hypoxia-selective cytotoxins: Model studies with nitroarylmethyl quaternary salts. Anti-Cancer Drug Des. 13, 663-685 (1998).
25. A. G. Kriste, M. Tercel, S. M. Stribbling, K. J. Botting and W. R. Wilson, Radiation-activated prodrugs: Hypoxia-selective radiolytic release of potent chloromethylbenzindoline (CBI) cytotoxins from novel nitroarylmethyl quaternary (NMQ) prodrugs. Br. J. Cancer 86 (Suppl. 1), 530-531 (2002).
26. W. R. Wilson, D. M. Ferry, M. Tercel, R. F. Anderson and W. A. Denny, Reduction of nitroarylmethyl quaternary ammonium prodrugs of mechlorethamine by radiation. Radiat. Res. 149, 237-245 (1998).
27. P. Neta and D. Behar, Intramolecular electron transfer in the anion radicals of nitrobenzyl halides. J. Am. Chem. Soc. 102, 4798-4802 (1980).
28. J. P. Bays, S. T. Blumer, S. Baral-Tosh, D. Behar and P. Neta, Intramolecular electron transfer and dehalogenation of nitroaromatic anion radicals. J. Am. Chem. Soc. 105, 320-324 (1983).
29. R. K. Norris, S. D. Barker and P. Neta, Steric effects of dehalogenation of anion radicals derived from substituted nitrobenzyl halides. J. Am. Chem. Soc. 106, 3140-3144 (1984).
30. R. F. Anderson, W. A. Denny, W. Li, J. E. Packer, M. Tercel and W. R. Wilson, Pulse radiolysis studies on the fragmentation of arylmethyl quaternary nitrogen mustards by one-electron reduction in aqueous solution. J. Phys. Chem. 101. 9704-9709 (1997).
31. H. R. Snyder, L. A. Carpino, J. F. Zack and J. F. Mills, Synthesis of the thieno[3,2-b]pyrrole system. J. Am. Chem. Soc. 79, 2556-2559 (1957).
32. G. V. Buxton, Radiation chemistry of the liquid state: Water and homogeneous aqueous solution. In Radiation Chemistry: Principles and Applications (Farhataziz and M. A. J. Rodgers, Eds.), pp 321-349. VCH Publishers, New York, 1987.
33. H. Fricke and E. J. Hart, Chemical dosimetry. In Radiation Dosimetry, Vol. 2 (F. H. Attix and W. C. Roesch, Eds.), pp. 167-239. Academic Press, New York, 1966.
34. K. Bobrowski, Pulse radiolysis of aqueous solutions of benzyltrialkylammonium cations. Reactions with the primary transients from water radiolysis. J. Phys. Chem. 85, 382-388 (1981).
35. M. E. Gamcsik, T. G. Hamill and M. Colvin, NMR studies of the conjugation of mechlorethamine with glutathione. J. Med. Chem. 33, 1009-1014 (1990).
36. P. L. Levins and Z. B. Papanastassiou, A nuclear magnetic resonance study of the 2-haloethylamines. J. Am. Chem. Soc. 87, 826-831 (1965).
37. M. A. Naylor, E. Swann, S. A. Everett, M. Jaffar, J. Nolan, N. Robertson, S. D. Lockyer, K. B. Patel, M. F. Dennis and I. J. Stratford, Indolequinone antitumor agents: Reductive activation and elimination from (5-methoxy-l-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro. J Med Chem. 41, 2720-2731 (1998).
38. S. A. Everett, M. A. Naylor, P. B. Barraja, E. Swann, K. B. Patel, M. R. Stratford, A. R. Hudnott, B. Vojnovic, R. J. Locke and C. J. Moody, Controlling the rates of reductively-activated elimination from the (indol-3-yl)methyl position of indolequinones. J. Chem. Soc. Perkin Trans. 2 5, 843-860 (2001).
39. E. Swann, C. J. Moody, M. R. Stratford, K. B. Patel, M. A. Naylor, B. Vojnovic, P. Wardman and S. A. Everett, Rates of reductive elimination of substituted nitrophenols from the (indol-3-yl)methyl position of indolequinones. J. Chem. Soc. Perkin Trans. 28, 1340-1345 (2001).